US Stats News reports that the new influenza vaccine has started an important trial. The placebo-controlled study at the National Institutes of Health Clinical Center in Bethesda, Maryland will test its safety and whether it can stimulate an immune response in healthy adults aged 18 – 55 years old led by Matthew J Memoli MD researcher from NIAID’s single-site research team!
Potential Universal Flu Vaccine
Scientists are getting closer than ever to a universal flu vaccine. This cocktail has already gone through animal testing and is slated to begin Phase I clinical trials this month. The vaccine so far looks very promising. This is a game-changer!
“The scientific community is making progress on this pressing global health priority. The BPL-1357 candidate influenza vaccine being tested in this clinical trial performed very well in pre-clinical studies and we look forward to learning how it performs in people.”
